Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants and penile implants. Aesthetic Implants are the devices intended to enhance the physical appearance and improve their image. GlobalData uses proprietary data and analytics to provide a comprehensive report on the aesthetic implants devices market, including market shares of different players within New Zealand. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights New Zealand Aesthetic Implants Market Share

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the aesthetic implants market in New Zealand was Mentor Worldwide followed by Establishment Labs, GC Aesthetics, POLYTECH Health & Aesthetics, Boston Scientific, Stryker, DePuy Synthes, Allergan Aesthetics and Coloplast.

Implantation is usually performed for cosmetic purposes as well as to rectify the deformed shape of the organ. Breast Implants, Face implants and Penile implants has been tracked here. Breast Implants includes the Sizers, Expanders, Premium round gel Implants, Round gel Implants, Saline Implants and Shaped gel Implants. Face implants are the especially formed solid materials (such as silicone) compatible with human tissues, designed to enhance or augment the physical structure of your face. Penile implants are the devices placed inside the penis to allow men with erectile dysfunction to get an erection.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the aesthetic implants devices market within New Zealand was expected to be over $6m in 2022.

For the latest complete market share analysis of aesthetic implants device market in New Zealand, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.